PuSH

    Tyrosine-1 of RNA polymerase II CTD controls global termination of gene transcription in mammals.

    No full text
    The carboxy-terminal domain (CTD) of RNA polymerase (Pol) II is composed of a repetition of YSPTSPS heptads and functions as a loading platform for protein complexes that regulate transcription, splicing, and maturation of RNAs. Here, we studied mammalian CTD mutants to analyze the function of tyrosine1 residues in the transcription cycle. Mutation of 3/4 of the tyrosine residues (YFFF mutant) resulted in a massive read-through transcription phenotype in the antisense direction of promoters as well as in the 3' direction several hundred kilobases downstream of genes. The YFFF mutant shows reduced Pol II at promoter-proximal pause sites, a loss of interaction with the Mediator and Integrator complexes, and impaired recruitment of these complexes to chromatin. Consistent with these observations, Pol II loading at enhancers and maturation of snRNAs are altered in the YFFF context genome-wide. We conclude that tyrosine1 residues of the CTD control termination of transcription by Pol II

    Changes of the tRNA modification pattern during the development of <em>Dictyostelium discoideum</em>.

    No full text
    Dictyostelium discoideum is a social amoeba, which on starvation develops from a single-cell state to a multicellular fruiting body. This developmental process is accompanied by massive changes in gene expression, which also affect non-coding RNAs. Here, we investigate how tRNAs as key regulators of the translation process are affected by this transition. To this end, we used LOTTE-seq to sequence the tRNA pool of D. discoideum at different developmental time points and analyzed both tRNA composition and tRNA modification patterns. We developed a workflow for the specific detection of modifications from reverse transcriptase signatures in chemically untreated RNA-seq data at single-nucleotide resolution. It avoids the comparison of treated and untreated RNA-seq data using reverse transcription arrest patterns at nucleotides in the neighborhood of a putative modification site as internal control. We find that nucleotide modification sites in D. discoideum tRNAs largely conform to the modification patterns observed throughout the eukaroytes. However, there are also previously undescribed modification sites. We observe substantial dynamic changes of both expression levels and modification patterns of certain tRNA types during fruiting body development. Beyond the specific application to D. discoideum our results demonstrate that the developmental variability of tRNA expression and modification can be traced efficiently with LOTTE-seq

    Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors.

    No full text
    CAR T cell therapy remains ineffective in solid tumors, due largely to poor infiltration and T cell suppression at the tumor site. T regulatory (Treg) cells suppress the immune response via inhibitory factors such as transforming growth factor–β (TGF-β). Treg cells expressing the C-C chemokine receptor 8 (CCR8) have been associated with poor prognosis in solid tumors. We postulated that CCR8 could be exploited to redirect effector T cells to the tumor site while a dominant-negative TGF-β receptor 2 (DNR) can simultaneously shield them from TGF-β. We identified that CCL1 from activated T cells potentiates a feedback loop for CCR8+ T cell recruitment to the tumor site. This sustained and improved infiltration of engineered T cells synergized with TGF-β shielding for improved therapeutic efficacy. Our results demonstrate that addition of CCR8 and DNR into CAR T cells can render them effective in solid tumors

    Pulsatile bi-directional aerosol flow affects aerosol delivery to the intranasal olfactory region: A patient-specific computational study

    No full text
    The nasal olfactory region is a potential route for non-invasive delivery of drugs directly from the nasal epithelium to the brain, bypassing the often impermeable blood-brain barrier. However, efficient aerosol delivery to the olfactory region is challenging due to its location in the nose. Here we explore aerosol delivery with bi-directional pulsatile flow conditions for targeted drug delivery to the olfactory region using a computational fluid dynamics (CFD) model on the patient-specific nasal geometry. Aerosols with aerodynamic diameter of 1&nbsp;µm, which is large enough for delivery of large enough drug doses and yet potentially small enough for non-inertial aerosol deposition due to, e.g., particle diffusion and flow oscillations, is inhaled for 1.98&nbsp;s through one nostril and exhaled through the other one. The bi-directional aerosol delivery with steady flow rate of 4&nbsp;L/min results in deposition efficiencies (DEs) of 50.9 and 0.48% in the nasal cavity and olfactory region, respectively. Pulsatile flow with average flow rate of 4&nbsp;L/min (frequency: 45&nbsp;Hz) reduces these values to 34.4 and 0.12%, respectively, and it mitigates the non-uniformity of right-left deposition in both the cavity (from 1.77- to 1.33-fold) and the olfactory region (from 624- to 53.2-fold). The average drug dose deposited in the nasal cavity and the olfactory epithelium region is very similar in the right nasal cavity independent of pulsation conditions (inhalation side). In contrast, the local aerosol dose in the olfactory region of the left side is at least 100-fold lower than that in the nasal cavity independent of pulsation condition. Hence, while pulsatile flow reduces the right-left (inhalation-exhalation) imbalance, it is not able to overcome it. However, the inhalation side (even with pulsation) allows for relatively high olfactory epithelium drug doses per area reaching the same level as in the total nasal cavity. Due to the relatively low drug deposition in olfactory region on the exhalation side, this allows either very efficient targeting of the inhalation side, or uniform drug delivery by performing bidirectional flow first from the one and then from the other side of the nose

    Calcitonin gene-related peptide exerts inhibitory effects on autophagy in the heart of mice.

    No full text
    Calcitonin Gene-Related Peptide (CGRP) is a potent vasodilator peptide widely distributed in the central nervous system and various peripheral tissues, including cardiac muscle. However, its role in heart protein metabolism remains unknown. We examined the acute effects of CGRP on autophagy and the related signaling pathways in the heart mice and cultured neonatal cardiomyocytes. CGRP (100 μg kg−1; s.c.) or 0.9 % saline was injected in awake male C57B16 mice, and the metabolic profile was determined up to 60 min. In fed mice, CGRP drastically increased glycemia and reduced insulinemia, an effect that was accompanied by reduced cardiac phosphorylation levels of Akt at Ser473 without affecting FoxO. Despite these catabolic effects, CGRP acutely inhibited autophagy as estimated by the decrease in LC3II:LC3I and autophagic flux. In addition, the fasting-induced autophagic flux in mice hearts was entirely abrogated by one single injection of CGRP. In parallel, CGRP stimulated PKA/CREB and mTORC1 signaling and increased the phosphorylation of Unc51-like kinase-1 (ULK1), an essential protein in autophagy initiation. Similar effects were observed in cardiomyocytes, in which CGRP also inhibited autophagic flux and stimulated Akt and FoxO phosphorylation. These findings suggest that CGRP in vivo acutely suppresses autophagy in the heart of fed and fasted mice, most likely through the activation of PKA/mTORC1 signaling but independent of Akt

    Dosing intact birch pollen grains at the airliquid interface (ALI) to the immortalized human bronchial epithelial cell line BEAS-2B.

    No full text
    In real life, humans are exposed to whole pollen grains at the air epithelial barrier. We developed a system for in vitro dosing of whole pollen grains at the Air-Liquid Interface (ALI) and studied their effect on the immortalized human bronchial epithelial cell line BEAS-2B. Pollen are sticky and large particles. Dosing pollen needs resuspension of single particles rather than clusters, and subsequent transportation to the cells with little loss to the walls of the instrumentation i.e. in a straight line. To avoid high speed impacting insults to cells we chose sedimentation by gravity as a delivery step. Pollen was resuspended into single particles by pressured air. A pollen dispersion unit including PTFE coating of the walls and reduced air pressure limited impaction loss to the walls. The loss of pollen to the system was still about 40%. A linear dose effect curve resulted in 327-2834 pollen/cm2 (± 6.1%), the latter concentration being calculated as the amount deposited on epithelial cells on high pollen days. After whole pollen exposure, the largest differential gene expression at the transcriptomic level was late, about 7 hours after exposure. Inflammatory and response to stimulus related genes were up-regulated. We developed a whole pollen exposure air-liquid interface system (Pollen-ALI), in which cells can be gently and reliably dosed

    Innovative radiation oncology Together&nbsp;– Precise,&nbsp;Personalized,&nbsp;Human: Vision 2030 for radiotherapy&nbsp;&amp; radiation oncology in Germany.

    No full text
    Purpose: Scientific and clinical achievements in radiation, medical, and surgical oncology are changing the landscape of interdisciplinary oncology. The German Society for Radiation Oncology (DEGRO) working group of young clinicians and scientists (yDEGRO) and the DEGRO representation of associate and full professors (AKRO) are aware of the essential role of radiation oncology in multidisciplinary treatment approaches. Together, yDEGRO and AKRO endorsed developing a&nbsp;German radiotherapy&nbsp;&amp; radiation oncology vision 2030 to address future challenges in patient care, research, and education. The vision 2030 aims to identify priorities and goals for the next decade in the field of radiation oncology. Methods: The vision development comprised three phases. During the first phase, areas of interest, objectives, and the process of vision development were defined jointly by the yDEGRO, AKRO, and the DEGRO board. In the second phase, a&nbsp;one-day strategy retreat was held to develop AKRO and yDEGRO representatives’ final vision from medicine, biology, and physics. The third phase was dedicated to vision interpretation and program development by yDEGRO representatives. Results: The strategy retreat’s development process resulted in conception of the final vision “Innovative radiation oncology Together&nbsp;– Precise, Personalized, Human.” The first term “Innovative radiation oncology” comprises the promotion of preclinical research and clinical trials and highlights the development of a&nbsp;national committee for strategic development in radiation oncology research. The term “together” underpins collaborations within radiation oncology departments as well as with other partners in the clinical and scientific setting. “Precise” mainly covers technological precision in radiotherapy as well as targeted oncologic therapeutics. “Personalized” emphasizes biology-directed individualization of radiation treatment. Finally, “Human” underlines the patient-centered approach and points towards the need for individual longer-term career curricula for clinicians and researchers in the field. Conclusion: The vision 2030 balances the ambition of physical, technological, and biological innovation as well as a&nbsp;comprehensive, patient-centered, and collaborative approach towards radiotherapy&nbsp;&amp; radiation oncology in Germany

    Computer-aided design and synthesis of a new class of PEX14 inhibitors: substituted 2,3,4,5-tetrahydrobenzo[F][1,4]oxazepines as potential new trypanocidal agents.

    No full text
    African and American trypanosomiases are estimated to affect several million people across the world, with effective treatments distinctly lacking. New, ideally oral, treatments with higher efficacy against these diseases are desperately needed. Peroxisomal import matrix (PEX) proteins represent a very interesting target for structure- and ligand-based drug design. The PEX5-PEX14 protein-protein interface in particular has been highlighted as a target, with inhibitors shown to disrupt essential cell processes in trypanosomes, leading to cell death. In this work, we present a drug development campaign that utilizes the synergy between structural biology, computer-aided drug design, and medicinal chemistry in the quest to discover and develop new potential compounds to treat trypanosomiasis by targeting the PEX14-PEX5 interaction. Using the structure of the known lead compounds discovered by Dawidowski et al. as the template for a chemically advanced template search (CATS) algorithm, we performed scaffold-hopping to obtain a new class of compounds with trypanocidal activity, based on 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepines chemistry. The initial compounds obtained were taken forward to a first round of hit-to-lead optimization by synthesis of derivatives, which show activities in the range of low- to high-digit micromolar IC50 in the in vitro tests. The NMR measurements confirm binding to PEX14 in solution, while immunofluorescent microscopy indicates disruption of protein import into the glycosomes, indicating that the PEX14-PEX5 protein-protein interface was successfully disrupted. These studies result in development of a novel scaffold for future lead optimization, while ADME testing gives an indication of further areas of improvement in the path from lead molecules toward a new drug active against trypanosomes

    SARS-CoV-2 Infektionen während Reisen mit Bahn und Bus. Ein systematisches Review epidemiologischer Studien.

    No full text
    Ziel Das Ziel dieses Reviews ist es, epidemiologische Studien zum Ansteckungsrisiko mit SARS-CoV-2 bei Reisen mit Bahn und Bus zu identifizieren und kritisch auch im Hinblick auf die Übertragbarkeit für Deutschland zu bewerten. Methodik Systematisches Review basierend auf der Suche in zwei elektronischen Datenbanken (PubMed, Web of Science) nach dem Prinzip der „Preferred Reporting Items for Systematic Review and Meta-analysis“ (PRISMA) nach epidemiologischen Studien zu SARS-CoV-2 bzw. COVID-19 und Reisen mit der Bahn oder im Bus. Ergebnisse Die Suche in den beiden elektronischen Datenbanken lieferte 746 Publikationen. Davon erfüllten 55 die Auswahlkriterien und wurden in die Volltextrecherche einbezogen. Schließlich konnten 5 Originalpublikationen zur Beantwortung der Frage nach SARS-CoV-2-Infektionen im Zusammenhang mit Fernreisen per Bahn und 4 mit Bezug auf Busreisen herangezogen werden. Die Studien sind sehr heterogen und beziehen sich fast ausschließlich auf Fernreisen in China. Sie zeigen konsistent ein Ansteckungsrisiko, wenn infizierte Personen im gleichen Waggon oder Bus ohne Mund-Nasen Bedeckung (MNB) mitreisen. Das Risiko ist dabei nicht beschränkt auf jene Reisenden, die in unmittelbarer Nähe zu dem infizierten Mitreisenden sitzen. Trotz aller Unterschiede zwischen Reisen mit Bahn und Bus in China und Deutschland besteht kein grundsätzlicher Zweifel daran, dass die berichteten Ergebnisse aus China in qualitativer Hinsicht auch auf Deutschland zu übertragen sind. Allerdings muss berücksichtigt werden, dass die Ergebnisse der drei Schlüsselpublikationen überwiegend die Zeit vor dem Lockdown in China ohne die strikte Verwendung von MNB einschlossen. Somit bleibt die Frage, ob die Ergebnisse unter den gegenwärtigen Bedingungen mit MNB und virulenteren Virusmutationen ähnlich wären. Es wurde keine einzige Studie im Zusammenhang mit der Infektion bei Nutzung des öffentlichen Personennahverkehrs gefunden. Schlussfolgerungen Es gibt verschiedene Hinweise dafür, dass Reisen mit der Bahn mit einem deutlich niedrigeren Infektionsrisiko verbunden ist im Vergleich zum Ansteckungsrisiko im häuslichen Umfeld. Wegen fehlender Beobachtungsdaten wird man das Infektionsrisiko bei Fernreisen mit Bus und bei Nutzung des öffentlichen Personennahverkehrs auf der Grundlage des Luftaustausches im Fahrgastinnenraum, der Reisedauer, des Abstandes zu anderen Fahrgästen und letztendlich der Fahrgastdichte modellhaft abschätzen müssen
    PuSHis based in DE
    Repository Dashboard
    Do you manage PuSH? Access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard!